R&D | December 29, 2025
Akums and Sharda University ink MoU to bridge industry–academia gap
The primary goal of the collaboration is joint research into trending and next-generation molecules
The primary goal of the collaboration is joint research into trending and next-generation molecules
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
Subscribe To Our Newsletter & Stay Updated
